In leukemic cell models, expression and kinase activity of several proximal BCR effectors were enhanced by overexpression of UGT2B17, including the T-cell receptor effectors LCK and ZAP70, which are documented BCR signaling effectors in CLL cells [28,35]. This evidence concerns the gene UGT2B17 and B-cell chronic lymphocytic leukemia.